Literature DB >> 28424339

Discovery of Double-Stranded Genomic DNA in Circulating Exosomes.

Raghu Kalluri1, Valerie S LeBleu1.   

Abstract

It is becoming increasingly clear that small vesicles released from cells (extracellular vesicles [EVs]) represent a heterogeneous population implicated in cell-to-cell communication. The classifications and nomenclature of EVs are evolving as enrichment strategies and specific characteristics are being unraveled. At present, physical properties of EVs-namely, size, shape, and density-are often used to identify subpopulations of EVs. A distinct group of EVs, termed exosomes, largely defined by their small size (∼40-150 nm) and proposed subcellular origin, has been extensively studied in several aspects of cancer biology. Exosomes are implicated in modulating behavior of cancer cells as well as the immune and angiogenic responses in tumors, possibly contributing to cancer progression locally and systemically. Most intriguingly, the nucleic acid content of exosomes has been proposed to play a role in oncogenic transformation and transfer of cancer-specific genome to promote cancer pathogenesis. Here, we specifically focus on the discovery of exosomal DNA, studies related to the origin of genomic DNA in exosomes, and its utility in cancer diagnosis and disease monitoring.
© 2016 Kalluri and LeBleu; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28424339     DOI: 10.1101/sqb.2016.81.030932

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  60 in total

1.  Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation.

Authors:  Karoliina Stefanius; Kelly Servage; Marcela de Souza Santos; Hillery Fields Gray; Jason E Toombs; Suneeta Chimalapati; Min S Kim; Venkat S Malladi; Rolf Brekken; Kim Orth
Journal:  Elife       Date:  2019-05-28       Impact factor: 8.140

Review 2.  Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer.

Authors:  Colin Sheehan; Crislyn D'Souza-Schorey
Journal:  J Cell Sci       Date:  2019-10-15       Impact factor: 5.285

Review 3.  Emerging role of extracellular vesicles in the regulation of skeletal muscle adaptation.

Authors:  Ivan J Vechetti
Journal:  J Appl Physiol (1985)       Date:  2019-06-13

Review 4.  Exosomal therapy-a new frontier in regenerative medicine.

Authors:  Sathish Muthu; Asawari Bapat; Rashmi Jain; Naveen Jeyaraman; Madhan Jeyaraman
Journal:  Stem Cell Investig       Date:  2021-04-02

Review 5.  The biology, function, and biomedical applications of exosomes.

Authors:  Raghu Kalluri; Valerie S LeBleu
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

Review 6.  Exosomes in cancer development, metastasis, and immunity.

Authors:  Lin Zhang; Dihua Yu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-30       Impact factor: 10.680

Review 7.  Exosomes in Acquired Neurological Disorders: New Insights into Pathophysiology and Treatment.

Authors:  Nicole Osier; Vida Motamedi; Katie Edwards; Ava Puccio; Ramon Diaz-Arrastia; Kimbra Kenney; Jessica Gill
Journal:  Mol Neurobiol       Date:  2018-04-16       Impact factor: 5.590

Review 8.  Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.

Authors:  Himadri Patel; Pritish Nilendu; Devashree Jahagirdar; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cancer Biol Ther       Date:  2017-12-08       Impact factor: 4.742

9.  Assessment of Fetal Rhesus D and Gender with Cell-Free DNA and Exosomes from Maternal Blood.

Authors:  Büşra Yaşa; Orhan Şahin; Elif Öcüt; Mehmet Seven; Selçuk Sözer
Journal:  Reprod Sci       Date:  2020-09-23       Impact factor: 3.060

10.  Expression and DNA methylation profiles of EZH2-target genes in plasma exosomes and matched primary tumor tissues of the patients with diffuse large B-cell lymphoma.

Authors:  I C Barıs; S Hacıoglu; N S Turk; G O Cetın; S Zencır; G Bagcı; V Caner
Journal:  Clin Transl Oncol       Date:  2020-11-23       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.